TY - JOUR AU - Kourakis, Stephanie AU - Timpani, Cara A. AU - Campelj, Dean G. AU - Hafner, Patricia AU - Gueven, Nuri AU - Fischer, Dirk AU - Rybalka, Emma PY - 2021 DA - 2021/03/04 TI - Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better? JO - Orphanet Journal of Rare Diseases SP - 117 VL - 16 IS - 1 AB - Pharmacological corticosteroid therapy is the standard of care in Duchenne Muscular Dystrophy (DMD) that aims to control symptoms and slow disease progression through potent anti-inflammatory action. However, a major concern is the significant adverse effects associated with long term-use. SN - 1750-1172 UR - https://doi.org/10.1186/s13023-021-01758-9 DO - 10.1186/s13023-021-01758-9 ID - Kourakis2021 ER -